Testosterone Solution
Product Images NDC 45802-610

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Testosterone (NDC 45802-610). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Israel Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
Chemical structure of testosterone, showing its steroid framework with a molecular formula of C19H28O2 and a molecular weight of 288.4.*
FDA Label Image

Figure-1-graph (Figure 1 Graph)

Figure-1-graph (Figure 1 Graph)
A line graph depicting serum total testosterone concentration (ng/dL) over 24 hours after dosing at 0, 4, 8, 12, 16, 20, and 24 hours. The graph compares concentrations for 30 mg, 60 mg, and 90 mg doses of testosterone topical solution, showing time from dose on the x-axis and testosterone concentration on the y-axis with error bars for variability.*
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
Illustration of testosterone topical solution components showing a pump dispenser, an applicator cup, and a cap. The image is labeled as 'Testosterone Topical Solution Figure 1'.*
FDA Label Image

Figure-2-graph (Figure 2 Graph)

Figure-2-graph (Figure 2 Graph)
A line graph showing serum total testosterone concentration (ng/dL) over time (hours) from dose. Data points with error bars illustrate fluctuations in testosterone levels up to 24 hours post-dose, with marked upper and lower normal limit lines for reference.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
Illustration showing a hand holding a container while another hand is spraying a topical solution into it, demonstrating the use of the product's spray applicator.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
An instructional line drawing showing a man applying a topical solution to his underarm area. The image highlights the application technique with the man holding an open container near his underarm, indicating proper placement of the medication.*
FDA Label Image

Image 01

Image 01
Packaging label for Testosterone Topical Solution USP 30 mg/1.5 mL by Padagis Israel Pharmaceuticals Ltd. The label indicates a topical solution with each actuation delivering 1.5 mL of solution. The box contains 110 mL total to deliver 90 mL, distributed by Perrigo. Warnings about flammability and instructions to use with the enclosed applicator are noted.*
FDA Label Image

Serialization Template

Serialization Template
Text panel placeholder for product serial number, lot number, and expiration date information fields. The panel prompts insertion of the product's unique serial number, lot number, and expiration date details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.